Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Pål André HolmE"'
Autor:
Christian Qvigstad, Lars Q. Sørensen, Geir E. Tjønnfjord, Pål André Holme, Ingrid Pabinger, Cedric Hermans, Roseline d’Oiron, Robert Klamroth, Johannes Oldenburg, Natascha Marquardt, Peter Staritz, Olga Katsarou, Uri Martinowitz, Aharon Lubetsky, Gili Kenet, Annarita Tagliaferri, Maria Elisa Mancuso, Roger Schutgens, Pål André HolmE, Jerzy Windyga, Irena Zupan, Victor Jimenez Yuste, Ramiro Nunez, Philippe de Moerloose, Erik Berntorp, Jan Astermark, Campbell Tait, Gerry Dolan
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 5, Pp 102514- (2024)
Background: People with hemophilia often experience pain and suffer from comorbidities related to their bleeding disorder. Consequently, unemployment due to disability is prevalent among people with hemophilia. Objectives: To explore associations bet
Externí odkaz:
https://doaj.org/article/bbbcde5173814e1f8d9095c20136a013
Elevated FVIII levels in hereditary hemorrhagic telangiectasia: Implications for clinical management
Autor:
Ole Jakob Jørgensen, Johan Edvard Steineger, Andreas Hillarp, Erik Pareli Wåland, Pål André Holme, Ketil Heimdal, Sinan Dheyauldeen
Publikováno v:
Laryngoscope Investigative Otolaryngology, Vol 9, Iss 1, Pp n/a-n/a (2024)
Abstract Objectives The objective of this study was twofold: to determine the prevalence of arterial and venous thromboembolic events in the Norwegian Hereditary Hemorrhagic Telangiectasia (HHT) population, and to explore potential factors linked to
Externí odkaz:
https://doaj.org/article/008d2fa34dbe4fb092a7d2b9f4b29544
Autor:
Thor Ueland, Ingvild Hausberg, Trude Victoria Mørtberg, Tuva Børresdatter Dahl, Tøri Vigeland Lerum, Annika Michelsen, Trine Ranheim, Katerina Nezvalova Henriksen, Anne Ma Dyrhol-Riise, Pål André Holme, Trond Mogens Aaløkken, Ole Henning Skjønsberg, Andreas Barratt-Due, Maria Therese Ahlén, Pål Aukrust, Bente Halvorsen
Publikováno v:
Platelets, Vol 33, Iss 4, Pp 640-644 (2022)
Thromboembolic events are frequent and associated with poor outcome in severe COVID-19 disease. Anti-PF4/polyanion antibodies are related to heparin-induced thrombocytopenia (HIT) and thrombus formation, but data on these antibodies in unselected COV
Externí odkaz:
https://doaj.org/article/9c8faea0cf644ea8873a3334b0d07902
Autor:
Cedric Hermans, Jan Astermark, Manuela Carvalho, Gerry Dolan, Roseline d'Oiron, Pierre Fontana, Pål André Holme, Gili Kenet, Robert Klamroth, Maria Elisa Mancuso, Natascha Marquardt, Ramiro Nunez, Olga Katsarou, Ingrid Pabinger‐Fasching, Gabriele Quintavalle, Ryan Rodgers, Paul van der Valk, Jerzy Windyga, Victor Jimenez Yuste, Irena Preložnik Zupan
Publikováno v:
Haemophilia. 29:913-916
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bd2fd703c12772b9ffbcf53d9300b22
https://doi.org/10.1111/hae.14761
https://doi.org/10.1111/hae.14761
Publikováno v:
Haemophilia. 29:658-667
Introduction: Limited evidence exists on objectively measured habitual physical activity (PA) of young people with haemophilia (PWH). Aims: To compare different outcomes of objective PA between young PWH A and controls using a commercial activity tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::693d083cbee6ef47b1e351713719076e
https://doi.org/10.1111/hae.14752
https://doi.org/10.1111/hae.14752
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 28(6)
Introduction: Measurement of physical activity (PA) using commercial activity trackers such as Fitbit devices has become increasingly popular, also for people with haemophilia (PWH). The accuracy of the Fitbit model Charge 3 has not yet been examined
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f333a73915f1fe79c4cf1ca2f0d39315
https://pubmed.ncbi.nlm.nih.gov/35830613
https://pubmed.ncbi.nlm.nih.gov/35830613
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 28(5)
Introduction Perioperative dosing recommendations vary across Nordic haemophilia treatment centres (HTCs) for extended half-life (EHL) factor concentrates in haemophilia A/B (HA/HB) patients. Aim To summarise Nordic real-world surgical experiences wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::103757b68d39a62223f74393e174d130
https://pubmed.ncbi.nlm.nih.gov/35575446
https://pubmed.ncbi.nlm.nih.gov/35575446
Aim The aim of this study was to investigate if prophylactic treatment in severe haemophilia impact on bone mineral densisty (BMD) in adults with haemophilia A/B. Methods Subjects with haemophilia (n = 120) underwent bone-density measurement and clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eec566ac78f6158cf894cfa6c00e9e62
http://hdl.handle.net/10852/97720
http://hdl.handle.net/10852/97720
Autor:
Jan Astermark, Fariba Baghaei, Karin Strandberg, Petra Gabric Toplican, Maj Friberg Birkedal, Emma Engman Grahn, Charlotta Hansson, Peter Kampmann, Anna-Elina Lehtinen, Kinga Täckström, Pål Andre Holme, Maria Magnusson
Publikováno v:
Therapeutic Advances in Hematology, Vol 14 (2023)
Background: Despite improvements in hemophilia care, challenges remain, including treatment burden and impaired quality of life. Gene therapy may overcome these. However, its introduction presents a challenge. Objectives: To outline a function-based
Externí odkaz:
https://doaj.org/article/0aa66564770c45379d3d4469b3bab69c
Autor:
Mark T. Reding, Ingrid Pabinger, Pål Andrè Holme, Monika Maas Enriquez, Maria Elisa Mancuso, Shadan Lalezari, Wolfgang Miesbach, Giovanni Di Minno, Robert Klamroth, Cedric Hermans
Publikováno v:
Therapeutic Advances in Hematology, Vol 14 (2023)
Background: Advances in treatment have enabled patients with haemophilia A to live longer and therefore may be subjected to comorbidities associated with ageing, in addition to disease-associated morbidities. There have been few reports to date on ef
Externí odkaz:
https://doaj.org/article/3106ae96a0814ef99d906c776d898f7c